![Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy](https://oncodaily.com/pub/uploads/2024/08/gdLSE1h_400x400-e1724151565609.jpg)
Photo from Elias Karam/LinkedIn
Aug 22, 2024, 15:06
Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy
Authors: Rik J. Verheijden, Jolien S. de Groot, Babs O. Fabriek, Miki N. Hew, Anne M. May and Karijn P.M. Suijkerbuijk.
“The ultimate dilemma of corticosteroids and Immunotherapy…
Large analysis of 6 clinical trials.
Take away messages:
- Higher corticosteroid peak dose is associated with worse survival across tumor types, while cumulative dose is not.
- Start with lower corticosteroid dose whenever feasible and try not to peak very high.”